Trial record 1 of 1 for: NCT00624338
Previous Study | Return to List | Next Study
Atacicept Phase 2/3 in Generalized Systemic Lupus Erythematosus (APRIL-SLE) (APRIL-SLE)
This study has been completed.
First Posted: February 27, 2008
Last Update Posted: March 14, 2016
Information provided by (Responsible Party):